The Beginning of a New Era for the Treatment of HCV
Douglas T. Dieterich, MD
Professor of Medicine, Division of Liver Diseases,
Director of Outpatient Hepatology,
Icahn School of Medicine at Mount Sinai, New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2013. All rights reserved.
Doug Dieterich is currently Professor of Medicine in the Division of Hepatology, with a triple appointment in the divisions of Liver Disease, Gastroenterology, and Infectious Diseases at the Icahn School of Medicine at Mount Sinai in New York City. He is an investigator for several ongoing studies evaluating the safety and efficacy of various antiviral treatment regimens for chronic hepatitis B & C. He has served on several committees of the AIDS Clinical Trials Group at the National Institutes of Health (NIH), including the Steering Committee of the Opportunistic Infections Core Committee and the Cytomegalovirus (CMV) Committee. He was Chair and Co-Chair, respectively, of the Enteric Parasites Committee and the Protozoan Committee. He also served on the NIH Study Sections for CMV and cryptosporidiosis. Widely published, Dr. Dieterich is the author of numerous journal articles, abstracts and book chapters on viral hepatitis and AIDS associated infections of the gastrointestinal tract and liver.
At the completion of this educational session, learners will:
- Appreciate the history of HCV treatment with and without HIV coinfection.
- Understand the use of directly acting agents (DAAs) for HCV.
- Be aware of the new all-oral combinations for HCV treatment.
This CME activity was approved for AMA PRA Category 1 Credit™
on December 17, 2013 and will terminate December, 2016.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Dieterich (Presenter) had the following personal financial relationships in the preceding 12 months with manufacturers of the products or services that may be presented in this CME activity: Grants/Research Recipient, Board Member, Advisor/Review Panel Member, Consultant, Speakers Bureau, and Honorarium Recipient with AbbVie, Boehringher Ingelheim, Bristol-Myers Squibb, Gilead, Merck, and Vertex. Dr. Dieterich supported his presentation and clinical recommendations with the best available evidence from the medical literature, and submitted his slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences, Janssen Therapeutics, and Merck & Co.
This PRN web site does not have the capacity to score quizzes and permit the download of CME certificates. To obtain CME credit for this and other PRN programs, please visit the PRN Video Channel
at the Clinical Education Initiative (CEI) web site http://www.ceitraining.org/prn-video/. PRN and the Medical Society of the State of New York (MSSNY) jointly provide PRN enduring materials for CME at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.